Name: Ginkgo Bioworks Holdings, Inc. (DNA) Financial Statements
Creator: FinSpry

Ginkgo Bioworks Holdings Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scale:

Scroll to see more

Ginkgo Bioworks Holdings, Inc. income statement - Annual data in billions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.23	0.25	0.48	0.31	0.08
Cost of Revenue	0.04	0.05	0.18	0.13	0.02
Gross Profit	0.18	0.20	0.29	0.18	0.06
Operating Expenses
Research & Development	0.42	0.58	1.05	1.15	0.16
Selling, General & Administrative	0.25	0.35	1.43	0.86	0.04
Operating Expenses	0.67	0.93	2.69	2.01	0.20
Operating Income	-0.49	-0.73	-2.21	-1.83	-0.14
Other Income/Expense
Interest Income	0.04	0.06	0.02	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	-0.10	0.01	-0.06	-0.01	0.01
Income
Income Before Tax	-0.55	-0.89	-2.12	-1.84	-0.12
Income Tax Expense	0.00	0.00	-0.02	0.00	0.00
Net Income	-0.55	-0.89	-2.10	-1.83	-0.13
Net Income - Continuous Operations	-0.55	-0.89	-2.11	-1.84	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-0.48	-0.66	-2.05	-1.81	-0.12
EBIT	-0.55	-0.73	-2.12	-1.84	-0.14
Depreciation & Amortization	0.06	0.07	0.04	0.03	0.01
Earnings Per Share
Basic EPS	-11.00	-18.00	-1.00	-54.00	-4.00
Diluted EPS	-11.00	-18.00	-1.00	-56.00	-4.00
Basic Shares Outstanding	0.05	0.05	1.68	0.03	0.03
Diluted Shares Outstanding	0.05	0.05	1.68	0.03	0.03